Biomaxima SA(PL:BMX)
zł 8.52-0.08 (-1.84%)
PL:BMX
Biomaxima SA financials statements
zł 8.52
At close:-0.08 (-1.84%)
Biomaxima SA (BMX) Ratios
1 Followers
Biomaxima SA Ratios
PL:BMX's free cash flow for Q2 2026 was zł211.00K. For the 2026 fiscal year, PL:BMX's free cash flow was decreased by zł-41.00K and operating cash flow was zł252.00K. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.74 | 1.48 | 2.19 | 3.30 | 1.93 |
| Quick Ratio | 0.83 | 0.70 | 0.96 | 2.13 | 1.13 |
| Cash Ratio | 0.12 | 0.05 | 0.14 | 1.18 | 0.02 |
| Solvency Ratio | 0.16 | 0.13 | 0.11 | 1.41 | 0.37 |
| Operating Cash Flow Ratio | 0.16 | -0.01 | 0.15 | 3.38 | -0.01 |
| Short-Term Operating Cash Flow Coverage | 0.38 | -0.02 | 0.45 | 28.40 | -0.02 |
| Net Current Asset Value | zł 2.28M | zł -3.57M | zł -3.98M | zł 14.26M | zł 809.00K |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.19 | 0.19 | 0.17 | 0.08 | 0.28 |
| Debt-to-Equity Ratio | 0.30 | 0.31 | 0.27 | 0.11 | 0.59 |
| Debt-to-Capital Ratio | 0.23 | 0.24 | 0.21 | 0.10 | 0.37 |
| Long-Term Debt-to-Capital Ratio | 0.12 | 0.10 | 0.15 | 0.07 | 0.22 |
| Financial Leverage Ratio | 1.61 | 1.61 | 1.57 | 1.42 | 2.12 |
| Debt Service Coverage Ratio | 0.48 | 0.50 | 0.89 | 17.63 | 1.46 |
| Interest Coverage Ratio | -0.11 | 1.34 | 1.20 | 73.38 | 52.11 |
| Debt to Market Cap | 0.25 | 0.31 | 0.17 | 0.05 | 0.14 |
| Interest Debt Per Share | 3.73 | 3.72 | 3.12 | 1.46 | 4.06 |
| Net Debt to EBITDA | 3.56 | 2.95 | 3.46 | -0.18 | 1.15 |
| Profitability Margins | |||||
| Gross Profit Margin | 2.75% | 44.01% | 42.80% | 37.69% | 36.66% |
| EBIT Margin | -0.22% | 2.43% | 1.70% | 25.26% | 16.48% |
| EBITDA Margin | 5.86% | 8.79% | 7.02% | 26.67% | 18.68% |
| Operating Profit Margin | -0.22% | 2.47% | 1.56% | 24.23% | 17.26% |
| Pretax Profit Margin | 0.31% | 0.58% | 0.40% | 24.93% | 16.15% |
| Net Profit Margin | 0.17% | 1.01% | 1.25% | 20.08% | 12.95% |
| Continuous Operations Profit Margin | 0.17% | 1.01% | 1.25% | 20.08% | 12.95% |
| Net Income Per EBT | 55.85% | 174.84% | 313.37% | 80.53% | 80.18% |
| EBT Per EBIT | -139.26% | 23.39% | 25.69% | 102.91% | 93.57% |
| Return on Assets (ROA) | 0.14% | 0.70% | 0.79% | 38.81% | 16.54% |
| Return on Equity (ROE) | 0.22% | 1.13% | 1.25% | 55.07% | 35.09% |
| Return on Capital Employed (ROCE) | -0.22% | 2.21% | 1.15% | 54.94% | 30.63% |
| Return on Invested Capital (ROIC) | -0.11% | 1.92% | 1.08% | 43.07% | 20.56% |
| Return on Tangible Assets | 0.14% | 0.70% | 0.80% | 39.04% | 16.67% |
| Earnings Yield | 0.21% | 1.19% | 0.83% | 25.97% | 9.02% |
| Efficiency Ratios | |||||
| Receivables Turnover | 8.32 | 4.80 | 6.60 | 14.27 | 4.95 |
| Payables Turnover | 12.06 | 6.97 | 7.78 | 23.23 | 11.34 |
| Inventory Turnover | 4.35 | 2.19 | 2.10 | 6.99 | 3.57 |
| Fixed Asset Turnover | 1.21 | 1.05 | 0.92 | 3.81 | 2.89 |
| Asset Turnover | 0.79 | 0.69 | 0.63 | 1.93 | 1.28 |
| Working Capital Turnover Ratio | 6.29 | 5.11 | 2.49 | 6.94 | 5.55 |
| Cash Conversion Cycle | 97.50 | 190.35 | 182.58 | 62.07 | 143.76 |
| Days of Sales Outstanding | 43.88 | 76.02 | 55.33 | 25.58 | 73.77 |
| Days of Inventory Outstanding | 83.90 | 166.72 | 174.19 | 52.21 | 102.18 |
| Days of Payables Outstanding | 30.27 | 52.38 | 46.93 | 15.71 | 32.19 |
| Operating Cycle | 127.77 | 242.74 | 229.51 | 77.79 | 175.95 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.56 | -0.04 | 0.37 | 8.57 | -0.03 |
| Free Cash Flow Per Share | 0.32 | -0.58 | -3.82 | 6.28 | -1.07 |
| Dividend Paid and CapEx Coverage Ratio | 2.34 | -0.07 | 0.08 | 3.13 | -0.02 |
| Capital Expenditure Coverage Ratio | 2.34 | -0.07 | 0.09 | 3.75 | -0.03 |
| Operating Cash Flow Coverage Ratio | 0.16 | -0.01 | 0.12 | 6.36 | -0.01 |
| Operating Cash Flow to Sales Ratio | 0.04 | -0.00 | 0.03 | 0.26 | -0.00 |
| Free Cash Flow Yield | 2.65% | -5.40% | -23.25% | 24.45% | -4.06% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 482.00 | 83.86 | 120.99 | 3.85 | 11.09 |
| Price-to-Sales (P/S) Ratio | 0.83 | 0.85 | 1.52 | 0.77 | 1.44 |
| Price-to-Book (P/B) Ratio | 1.05 | 0.95 | 1.51 | 2.12 | 3.89 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 37.79 | -18.52 | -4.30 | 4.09 | -24.62 |
| Price-to-Operating Cash Flow Ratio | 21.63 | -295.17 | 44.54 | 3.00 | -860.73 |
| Price-to-Earnings Growth (PEG) Ratio | -5.97 | -11.74 | -1.24 | 0.02 | 0.49 |
| Enterprise Value Multiple | 17.71 | 12.61 | 25.05 | 2.71 | 8.84 |
| Enterprise Value | 63.25M | 58.58M | 82.26M | 104.13M | 130.58M |
| EV to EBITDA | 17.71 | 12.61 | 25.05 | 2.71 | 8.84 |
| EV to Sales | 1.04 | 1.11 | 1.76 | 0.72 | 1.65 |
| EV to Free Cash Flow | 47.30 | -24.19 | -4.99 | 3.83 | -28.30 |
| EV to Operating Cash Flow | 27.07 | -385.37 | 51.67 | 2.81 | -989.23 |
| Tangible Book Value Per Share | 12.68 | 11.21 | 10.79 | 12.02 | 6.64 |
| Shareholders’ Equity Per Share | 11.47 | 11.29 | 10.88 | 12.12 | 6.76 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.44 | -0.75 | -2.13 | 0.19 | 0.20 |
| Revenue Per Share | 14.52 | 12.60 | 10.84 | 33.25 | 18.31 |
| Net Income Per Share | 0.03 | 0.13 | 0.14 | 6.68 | 2.37 |
| Tax Burden | 0.56 | 1.75 | 3.13 | 0.81 | 0.80 |
| Interest Burden | -1.39 | 0.24 | 0.23 | 0.99 | 0.98 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.03 | 0.03 | 0.00 | 0.00 | 0.06 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 22.25 | -0.50 | 2.72 | 1.03 | -0.01 |
Currency in PLN
